Thienoacene-Based Conjugated Oligoelectrolytes for Membrane-Targeting Antimicrobial Approaches: Synergistic Biofilm Eradication and Antimicrobial Resistance Reversal.

Abstract

Membrane-targeting antimicrobials represent a promising class of materials to combat the escalating issue of antimicrobial resistance. Herein, we report a series of membrane-targeting conjugated oligoelectrolytes (COE-nT) featuring thienoacene moieties as π-conjugated cores, designed for tackling antimicrobial resistance. COE-nT exhibited higher activity against Gram-positive bacteria compared to Gram-negative bacteria, with no intrinsic resistance observed in either drug-resistant strain. Notably, a reduction in the π-conjugated length of COE-nT correlated with an increase in membrane permeability and toxicity toward cells and animals. Moreover, COE-nT demonstrated synergistic effects with commercial antibiotics against drug-resistant strains and restored susceptibility to ribosome-targeting antibiotics, such as clindamycin and erythromycin. To illustrate their synergistic potential, the combination of COE-4T and mupirocin was employed to treat methicillin-resistant Staphylococcus aureus infections in a murine wound model, resulting in significant biofilm eradication and enhanced antimicrobial efficacy. This new series of thienoacene-based COEs expands the antimicrobial COEs library with defined structure-activity relationship profiles and demonstrates its potential as a powerful adjunctive therapy for overcoming antimicrobial resistance.